Status:
TERMINATED
Schizophrenic Patients Taking Part in Integrated Care Program
Lead Sponsor:
AstraZeneca
Collaborating Sponsors:
acromion GmbH
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18-65 years
Brief Summary
Purpose of this non-interventional study (NIS) is to assess the effect of the participation in an integrated care program on treatment outcomes in patients treated with Seroquel for schizophrenia.
Eligibility Criteria
Inclusion
- Outpatients suffering from schizophrenia, schizoaffective disorder, schizophreni-form disorder, delusional disorder or psychotic disorder not otherwise specified
- Age 18 - 65 years
- Current stable treatment with Seroquel according to SmPC since at least 2 months
- Given consent to take part in an integrated care program prior to study startWritten informed consent to take part in this NIS
Exclusion
- Presence of any contraindication as described in the SmPC
- Cancellation of participation in the integrated care program
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00617214
Start Date
January 1 2008
End Date
December 1 2008
Last Update
December 10 2010
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Ahrweiler, Germany
2
Research Site
Berlin, Germany
3
Research Site
Bonn, Germany
4
Research Site
Hamburg, Germany